

10 Nov 2025
// BUSINESS WIRE
https://www.businesswire.com/news/home/20251021956399/en/Quince-Therapeutics-Announces-Positive-iDSMB-Review-for-eDSP-in-Pivotal-Phase-3-NEAT-Clinical-Trial-in-Ataxia-Telangiectasia

25 Sep 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250925856162/en/Quince-Therapeutics-Announces-CPT-Pharmacometrics-Systems-Pharmacology-Publication-of-eDSP-Population-Pharmacokinetic-Modeling-Study

26 Jun 2024
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-26-2024-3489.pdf

03 Jun 2024
// BUSINESSWIRE

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211451
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214890